Category Archives: Uncategorized

  • HDACi clinical trial starts in Turin

    Posted on 9th April 2012 by Caroline in Uncategorized.

    Repligen Corp. (NASDAQ:RGEN) in Waltham has enrolled (March 2012) its first patient in a Phase 1 clinical trial of RG2833 in adult patients with Friedreich’s ataxia (FA), see http://www.masshightech.com/stories/2012/03/12/daily57-Repligen-begins-clinical-trial-of-drug-for-Friedreichs-ataxia.html Repligen also reported it’s year-end financial results for 2011, according to two announcements this week. The RG2833 drug candidate is an oral class 1 histone deacetylase […]

    Continue Reading...
    Comments Off on HDACi clinical trial starts in Turin
  • FARA Ireland

    Posted on 30th May 2011 by Caroline in Uncategorized.

    Welcome to the FARA Ireland website. With your help we hope to become the driving force behind raising funds for research into Friedreich’s Ataxia.

    Post Tagged with
    Continue Reading...
    Comments Off on FARA Ireland